Efficacy and safety of CT-guided high-dose-rate interstitial brachytherapy in primary and secondary malignancies of the pancreas
Authors:
- 1 March 2019
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 112, 22-27
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group TrialJournal of Clinical Oncology, 2011
- Computed Tomography–Guided Brachytherapy for Liver CancerSeminars in Radiation Oncology, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Patterns of recurrence after curative resection of pancreatic ductal adenocarcinomaEuropean Journal of Surgical Oncology, 2009
- Surgery for secondary tumors of the pancreasHPB, 2008
- Metastatic Disease to the Pancreas and SpleenSeminars in Oncology, 2008
- Most Pancreatic Cancer Resections are R1 ResectionsAnnals of Surgical Oncology, 2008
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinomaBritish Journal of Surgery, 2004
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990